Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

PHASE1RecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 13, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Breast Cancer
Interventions
DRUG

Azelaic Acid

A thin layer of Azelaic acid should be applied to the entire area of radiation treatment twice daily, each day of the week (including weekends) starting one week prior to the start of radiation, then during the entire course of radiation treatment (usually 3-5 weeks), and for 3 weeks following the completion of radiation treatment.

Trial Locations (1)

23298

RECRUITING

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER